UniProt ID | CD166_HUMAN | |
---|---|---|
UniProt AC | Q13740 | |
Protein Name | CD166 antigen | |
Gene Name | ALCAM | |
Organism | Homo sapiens (Human). | |
Sequence Length | 583 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Cell projection, axon . Cell projection, dendrite . Detected at the immunological synapse, i.e, at the contact zone between antigen-presenting dendritic cells and T-cells (PubMed:15294938, PubMed: |
|
Protein Description | Cell adhesion molecule that mediates both heterotypic cell-cell contacts via its interaction with CD6, as well as homotypic cell-cell contacts. [PubMed: 7760007] | |
Protein Sequence | MESKGASSCRLLFCLLISATVFRPGLGWYTVNSAYGDTIIIPCRLDVPQNLMFGKWKYEKPDGSPVFIAFRSSTKKSVQYDDVPEYKDRLNLSENYTLSISNARISDEKRFVCMLVTEDNVFEAPTIVKVFKQPSKPEIVSKALFLETEQLKKLGDCISEDSYPDGNITWYRNGKVLHPLEGAVVIIFKKEMDPVTQLYTMTSTLEYKTTKADIQMPFTCSVTYYGPSGQKTIHSEQAVFDIYYPTEQVTIQVLPPKNAIKEGDNITLKCLGNGNPPPEEFLFYLPGQPEGIRSSNTYTLTDVRRNATGDYKCSLIDKKSMIASTAITVHYLDLSLNPSGEVTRQIGDALPVSCTISASRNATVVWMKDNIRLRSSPSFSSLHYQDAGNYVCETALQEVEGLKKRESLTLIVEGKPQIKMTKKTDPSGLSKTIICHVEGFPKPAIQWTITGSGSVINQTEESPYINGRYYSKIIISPEENVTLTCTAENQLERTVNSLNVSAISIPEHDEADEISDENREKVNDQAKLIVGIVVGLLLAALVAGVVYWLYMKKSKTASKHVNKDLGNMEENKKLEENNHKTEA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 (in isoform 4) | Phosphorylation | - | 5.15 | 29116813 | |
12 (in isoform 4) | Phosphorylation | - | 1.15 | 29116813 | |
52 | Sulfoxidation | LDVPQNLMFGKWKYE CCCCCCCEECEEEEE | 5.66 | 21406390 | |
64 | Phosphorylation | KYEKPDGSPVFIAFR EEECCCCCEEEEEEE | 25.85 | 110750185 | |
80 | Phosphorylation | STKKSVQYDDVPEYK CCCCCCCCCCCCCHH | 16.38 | 22817900 | |
86 | Phosphorylation | QYDDVPEYKDRLNLS CCCCCCCHHHHCCCC | 16.48 | 22817900 | |
87 | Ubiquitination | YDDVPEYKDRLNLSE CCCCCCHHHHCCCCC | 34.41 | 21906983 | |
87 (in isoform 2) | Ubiquitination | - | 34.41 | 21906983 | |
87 (in isoform 1) | Ubiquitination | - | 34.41 | 21906983 | |
87 | 2-Hydroxyisobutyrylation | YDDVPEYKDRLNLSE CCCCCCHHHHCCCCC | 34.41 | - | |
87 | Ubiquitination | YDDVPEYKDRLNLSE CCCCCCHHHHCCCCC | 34.41 | 21906983 | |
91 | N-linked_Glycosylation | PEYKDRLNLSENYTL CCHHHHCCCCCCEEE | 42.27 | 12754519 | |
95 | N-linked_Glycosylation | DRLNLSENYTLSISN HHCCCCCCEEEEEEC | 31.54 | 12754519 | |
95 | N-linked_Glycosylation | DRLNLSENYTLSISN HHCCCCCCEEEEEEC | 31.54 | 12754519 | |
117 | Phosphorylation | RFVCMLVTEDNVFEA CEEEEEECCCCEECC | 33.39 | 20639409 | |
126 | Phosphorylation | DNVFEAPTIVKVFKQ CCEECCCCEEECCCC | 45.51 | 20639409 | |
152 | 2-Hydroxyisobutyrylation | FLETEQLKKLGDCIS HHCHHHHHHHHCCCC | 45.72 | - | |
167 | N-linked_Glycosylation | EDSYPDGNITWYRNG CCCCCCCCEEEEECC | 35.58 | 12754519 | |
167 | N-linked_Glycosylation | EDSYPDGNITWYRNG CCCCCCCCEEEEECC | 35.58 | 12754519 | |
196 | Phosphorylation | KKEMDPVTQLYTMTS ECCCCCCCEEEEEEE | 20.46 | 24905233 | |
199 | Phosphorylation | MDPVTQLYTMTSTLE CCCCCEEEEEEEEEE | 5.66 | 24905233 | |
200 | Phosphorylation | DPVTQLYTMTSTLEY CCCCEEEEEEEEEEE | 23.67 | 24905233 | |
202 | Phosphorylation | VTQLYTMTSTLEYKT CCEEEEEEEEEEEEE | 15.68 | 24905233 | |
203 | Phosphorylation | TQLYTMTSTLEYKTT CEEEEEEEEEEEEEC | 21.85 | 24905233 | |
204 | Phosphorylation | QLYTMTSTLEYKTTK EEEEEEEEEEEEECC | 17.91 | 24905233 | |
207 | Phosphorylation | TMTSTLEYKTTKADI EEEEEEEEEECCCCE | 19.42 | 29116813 | |
209 | Phosphorylation | TSTLEYKTTKADIQM EEEEEEEECCCCEEC | 32.40 | 24905233 | |
210 | Phosphorylation | STLEYKTTKADIQMP EEEEEEECCCCEECC | 21.78 | 24905233 | |
265 | N-linked_Glycosylation | NAIKEGDNITLKCLG CCCCCCCCEEEEECC | 39.75 | UniProtKB CARBOHYD | |
265 | N-linked_Glycosylation | NAIKEGDNITLKCLG CCCCCCCCEEEEECC | 39.75 | 16335952 | |
298 | Phosphorylation | GIRSSNTYTLTDVRR CCCCCCEEEEECCHH | 12.19 | 110750197 | |
306 | N-linked_Glycosylation | TLTDVRRNATGDYKC EEECCHHHCCCCCEE | 31.15 | UniProtKB CARBOHYD | |
308 | Phosphorylation | TDVRRNATGDYKCSL ECCHHHCCCCCEEEE | 33.85 | 26699800 | |
311 | Phosphorylation | RRNATGDYKCSLIDK HHHCCCCCEEEECCC | 18.42 | 26699800 | |
314 | Phosphorylation | ATGDYKCSLIDKKSM CCCCCEEEECCCCHH | 24.98 | 26699800 | |
343 | O-linked_Glycosylation | LNPSGEVTRQIGDAL CCCCCCHHEECCCEE | 16.74 | OGP | |
361 | N-linked_Glycosylation | CTISASRNATVVWMK EEEEECCCCEEEEEE | 37.15 | 19349973 | |
361 | N-linked_Glycosylation | CTISASRNATVVWMK EEEEECCCCEEEEEE | 37.15 | 19349973 | |
375 | Phosphorylation | KDNIRLRSSPSFSSL ECCEEECCCCCCCCC | 51.71 | 28348404 | |
376 | Phosphorylation | DNIRLRSSPSFSSLH CCEEECCCCCCCCCE | 20.37 | 28348404 | |
378 | Phosphorylation | IRLRSSPSFSSLHYQ EEECCCCCCCCCEEE | 39.44 | 28348404 | |
380 | Phosphorylation | LRSSPSFSSLHYQDA ECCCCCCCCCEEECC | 36.01 | 28348404 | |
381 | Phosphorylation | RSSPSFSSLHYQDAG CCCCCCCCCEEECCC | 19.70 | 28348404 | |
407 | Phosphorylation | EGLKKRESLTLIVEG CCCCCCCCEEEEEEC | 30.59 | 26091039 | |
409 | Phosphorylation | LKKRESLTLIVEGKP CCCCCCEEEEEECCC | 24.58 | 26091039 | |
457 | N-linked_Glycosylation | TGSGSVINQTEESPY ECCCCCCCCCCCCCC | 40.33 | 19349973 | |
457 | N-linked_Glycosylation | TGSGSVINQTEESPY ECCCCCCCCCCCCCC | 40.33 | 19159218 | |
466 | N-linked_Glycosylation | TEESPYINGRYYSKI CCCCCCCCCEEEEEE | 24.05 | 19349973 | |
466 | N-linked_Glycosylation | TEESPYINGRYYSKI CCCCCCCCCEEEEEE | 24.05 | 19349973 | |
480 | N-linked_Glycosylation | IIISPEENVTLTCTA EEECCCCCEEEEEEC | 30.34 | 12754519 | |
480 | N-linked_Glycosylation | IIISPEENVTLTCTA EEECCCCCEEEEEEC | 30.34 | 12754519 | |
496 | N-linked_Glycosylation | NQLERTVNSLNVSAI HHHHHHHHEECEEEE | 39.92 | 19349973 | |
496 | N-linked_Glycosylation | NQLERTVNSLNVSAI HHHHHHHHEECEEEE | 39.92 | 19349973 | |
499 | N-linked_Glycosylation | ERTVNSLNVSAISIP HHHHHEECEEEEECC | 26.06 | 12754519 | |
499 | N-linked_Glycosylation | ERTVNSLNVSAISIP HHHHHEECEEEEECC | 26.06 | 12754519 | |
501 (in isoform 2) | Phosphorylation | - | 20.86 | 22617229 | |
518 | N-linked_Glycosylation | ADEISDENREKVNDQ HHCCCHHHHHHHHHH | 63.50 | 19349973 | |
518 | N-linked_Glycosylation | ADEISDENREKVNDQ HHCCCHHHHHHHHHH | 63.50 | 19349973 | |
550 (in isoform 2) | Ubiquitination | - | 7.85 | - | |
559 (in isoform 2) | Ubiquitination | - | 49.46 | 21906983 | |
559 | Acetylation | KKSKTASKHVNKDLG CCCHHHHHHHCHHCC | 49.46 | 19666643 | |
560 (in isoform 2) | Ubiquitination | - | 26.36 | 21906983 | |
563 | Ubiquitination | TASKHVNKDLGNMEE HHHHHHCHHCCCHHH | 53.92 | - | |
563 | Acetylation | TASKHVNKDLGNMEE HHHHHHCHHCCCHHH | 53.92 | 19666651 | |
567 (in isoform 2) | Ubiquitination | - | 41.83 | 21906983 | |
572 (in isoform 1) | Ubiquitination | - | 63.11 | 21906983 | |
572 | Ubiquitination | LGNMEENKKLEENNH CCCHHHHHHHHHCCC | 63.11 | 21906983 | |
573 (in isoform 1) | Ubiquitination | - | 73.11 | 21906983 | |
573 | Ubiquitination | GNMEENKKLEENNHK CCHHHHHHHHHCCCC | 73.11 | 2190698 | |
580 (in isoform 1) | Ubiquitination | - | 50.62 | 21906983 | |
580 | Ubiquitination | KLEENNHKTEA---- HHHHCCCCCCC---- | 50.62 | 21906983 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CD166_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CD166_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CD6_HUMAN | CD6 | physical | 7543097 | |
NAR3_HUMAN | ART3 | physical | 21988832 | |
LEG1_HUMAN | LGALS1 | physical | 28514442 | |
FBX2_HUMAN | FBXO2 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-457 AND ASN-466, AND MASSSPECTROMETRY. | |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-91; ASN-95; ASN-457 ANDASN-480, AND MASS SPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-95; ASN-265 AND ASN-499,AND MASS SPECTROMETRY. | |
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-91; ASN-167; ASN-480 AND ASN-499. |